Reshema Kemps-Polanco (She/Her)

Reshema Kemps-Polanco currently serves as the Executive Vice President and Chief Commercial Officer for Novartis US, responsible for the growth strategy and portfolio management across four therapeutic areas. With prior experience as the US Head of Novartis Oncology, Reshema has also held significant leadership positions at Johnson & Johnson, including President of Janssen Cardiovascular & Metabolism. Reshema's extensive background encompasses roles in marketing, strategic management, and commercialization, with a notable history at Novartis starting in 1999. In addition to current roles, Reshema serves on the Board of Directors for Charles River Laboratories. Academic credentials include an MBA from Rutgers Business School and an MA in Industrial/Organizational Behavior from Louisiana Tech University. Reshema is also a U.S. Army Reserve veteran.